INTRODUCTION
Portal hypertension is the increase in the portal vein pressure. It occurs as a result of cirrhosis when the change in hepatic architecture leads to increased resistance to the blood flow inside the portal vein tributaries [1, 2] . Esophageal varices are dilated blood vessels that appear at the gastroesopahgeal junction as a result of increased portal vein pressure. They occur when the hepatic venous pressure gradient reaches the critical point of 10 mmHg [3] . Patients with portal hypertension develop esophageal varices at a yearly incidence of 8%. The yearly incidence of variceal hemorrhage is 5%-15%. The most important risk factor for hemorrhage is the size of varices. The six week mortality after an episode of variceal bleeding is 20%. This mortality is still considered high in spite of the improvement of the endoscopic management strategies [4] . The Baveno VI consensus recommended the use of non-invasive markers to rule out the presence of esophageal varices, in order to help minimize the number of unnecessary endoscopies and confine endoscopy to patients who are at high risk of variceal bleeding [5] .
Von Willbrand factor is a coagulation factor secreted from the endothelial cells and it plays a role in both intrinsic and extrinsic pathways of coagulation [6] . The VITRO score is calculated by dividing the VWF Ag concentration on the platelet count it was first introduced by Maieron et al. together with VWF Ag, and among other well-known markers as a non-invasive predictor of cirrhosis [7] . They were also found to correlates well with liver function and hepatic venous pressure gradient and independently predicts clinical outcome [8] .
Aim of the work:
To study the role of Von Willebrand Factor (VWF-Ag) and VITRO score in the prediction of presence of Esophageal Varices and occurrence of variceal bleeding in cirrhotic patients.
PATIENTS AND METHODS
Our study was a prospective analytical crosssectional study. Sample size was calculated according to expected positive predictive value of 70, power of the study 85% and 95% confidence interval, population size is 1500/ year using EPI info 6.
It included 77 patients with liver cirrhosis and portal hypertension diagnosed by combination of clinical, radiological and laboratory evidence. They were randomly selected from patients admitted to tropical medicine endoscopy unit for upper GI endoscopy for the first time for diagnostic upper GI endoscopy either screening for esophageal varices or part of investigations of microcytic hypochromic anaemia or therapeutic upper GI endoscopy after an episode of upper GI bleeding. The following patients were excluded from the study; patients <18 years old, patients who didn't give consent to participate in the study, patients with known congenital or acquired coagulation defect due to a cause other than liver disease, patients on antiplatelet or anticoagulant therapy, patients with conditions that can lead to increased VWF Ag level such a pregnancy, sepsis, hyperlipidemia, cardiac or renal failure and finally, patients with intra or extrahepatic malignancy detected by history, clinical examination, basic radiological and laboratory evaluation.
On admission, patient underwent basic evaluation including thorough history taking and clinical examination. Patients also performed abdominal ultrasonography examination.
Portal hypertension was diagnosed based on sonographic evaluation of portal vasculature dilated portal vein, presence of collaterals around gall bladder bed or spleen hilum, the abolished changes in portal vein diameter with respiration, enlarged superior mesenteric and splenic veins and/orincresed spleen long axis>12 cm [9] .
Patients were subjected to routine laboratory investigations including; complete blood count and ESR, liver function tests namely serum albumin, bilirubin and serum transaminases, coagulation profile and kidney function tests namely serum BUN and serum creatinine. The severity of liver disease was classified according to Child- Table 1 summarizes the demographic, clinical, sonographic data of the patients. It shows that there were no significant differences between the studied groups as regards any of the demographic or clinical data. It represents also that the Child score show no statistically significant differences between the studied groups (8.5±2.4 in group I vs 9.9± 3 points in group II MW= 1.8 p=0.06). The comparison according to child grade showed no significant differences as regard the distribution of grades A, B and C in each group (23.7%, 44.1% and 32.2% successively in group I and 33.3%, 55.6% and 11.1% successively in group II p=0.2) Table 1 also shows comparison between the studied groups as regards portal vein diameter and spleen long axis as measured by sonographic examination of the patients. It shows that portal vein diameter not significantly higher among patients with varices (group I) (1.6±0.28 vs 1.5± 0.24 cm p=0.17). It also shows that the spleen long axis is significantly higher among patients in group I (17.6±1.6 vs 15.1±5.8 cm p=0.001), although clinically the size of the spleen showed no significant difference between the groups. Table 2 represents a comparison between the studied groups as regards routine laboratory parameters as well as VWF Ag level and VITRO score. The table shows there were no significant differences between the studied groups as regards any of the laboratory parameters. However, VWF Ag and Vitro score were significantly higher in the varices group (group I). VWF Ag level was 169.3 ± 20.2 in group I vs 146.8 ± 35.5 µg/dL in group II p<0.001. VITRO score was 2.2 ± 1.1 in group I vs 1.6 ± 0.7 µg/10 8 platelet p=0.05. Univariate and multivariate analysis: Table 4 represents the correlation between VWF and VITRO score with the different variables in the study. It shows that there is a positive correlation between VWF and patient's age (0.47 p<0.001), creatinine (0.34 p=0.004), and esophageal varices grade (0.42 p<0.001). There was also a significant negative correlation to hemoglobin (-0.23 p= 0.04) and to bilirubin (-0.26 p=0.02). The VITRO score was correlated to all of the above mentioned except bilirubin. It showed also a significant correlation to the spleen long axis (0.42 p<0.001) and to the platelet count (-0.68 p<0.001). Both scores revealed no statistically significant correlation to the PHG or to Child's score. 
RESULTS

DISCUSSION
Von Willbrand factor and VITRO score were proved by previous literature to have a correlation to liver cirrhosis, liver functions, severity of liver disease and portal hypertension. We aimed in this study to discover their role as non-invasive predictors of esophageal varices and risk of variceal bleeding among patients with liver cirrhosis. To achieve our aim we included 77 patients in our study randomly selected from the patients with liver cirrhosis admitted for diagnostic or therapeutic endoscopic intervention for the first time. Some of those patients were admitted after an episode of variceal bleeding. None of our patients had previous intervention that included any manipulation of esophageal varices to avoid the resultant impact on our results that this manipulation can cause. The patients were allocated into two groups according to the presence or absence of esophageal varices.
Comparison between the studied groups as regards their demographic, clinical, Child score revealed no significant differences as regards any of these data. This comes in favor of abolishing the effects of possible confounding factors. However, comparison of the studied groups as regards spleen long axis revealed that it was significantly higher among patients with esophageal varices. These findings come in agreement with Agha et al. The multivariate analysis for possible confounding factors revealed that VWF was independently correlated to the esophageal varices and that none of these variables correlated to the VWF confounded its relation to the esophageal varices. This comes in agreement with Ibrahim et al. [19] who found that VWF is an independent predictor of variceal bleeding [19] .
Our study revealed that VWF can be useful as a predictor of EV at a cut off value of 153%. It can also predict the presence of risky and bleeding varices at cut off value of 172.7. The previous literature gives variable results about this topic the cut off value ranged from 141% to 240%, the sensitivity ranges from 75% to over 90% and the specificity ranged from 76% to 100% 
CONCLUSION
VWF and VITRO score are independently correlated to the presence and grade of esophageal varices. Both markers were proved to be useful as predictors of the presence of EV. VWF factor can also help in prediction of the presence of risky and bleeding varices.
